MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Contributed by: Business Wire

Logo

Tags

Technology

Venture Capital

Professional Services

Software

Practice Management

Biotechnology

Health

Pharmaceutical

Data Management

MedaSystems

More Like This

Edward Kliphuis, Partner, Sofinnova Digital Medicine Strategy and Simon Turner, Partner, Sofinnova Digital Medicine Strategy (Photo: Sofinnova Partners)

Sofinnova Partners Raises $200M Digital Medicine Fund

PR Newswire associated0

Dawn Health Secures €11.5 Million to Scale Platform & Product Suite for Next-Gen Pharma Digital Health Solutions

BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development

Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research

Debiopharm to Reveal Insights From Their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at the 2025 AACR Conference in Chicago

Medidata Extends Its Commitment to the Patient Experience with the Launch of Patient Payments

Debiopharm Recognizes Groundbreaking Japanese Cancer Research During the 83rd Annual Meeting of the Japanese Cancer Association

Debiopharm to Showcase Research Results of Their First-in-class Anti-staphylococcal Program at IDWeek 2024 in Los Angeles